CXCL13 and lip and oral cavity carcinoma: Inversely, oral cancer-associated TLSs with upregulation of CXCL13 are linked to the extended survival of oral cancer patients, indicating the roles of TLSs as a prognostic marker and immune treatment for oral cancer [190].